| MeSH term | MeSH ID | Detail |
|---|---|---|
| Toxoplasmosis, Ocular | D014126 | 2 associated lipids |
| Typhoid Fever | D014435 | 2 associated lipids |
| Acquired Hyperostosis Syndrome | D020083 | 1 associated lipids |
| Central Nervous System Protozoal Infections | D020808 | 3 associated lipids |
| Syncope, Vasovagal | D019462 | 1 associated lipids |
| Leishmaniasis, Mucocutaneous | D007897 | 1 associated lipids |
| Trichiasis | D058457 | 1 associated lipids |
| Paratyphoid Fever | D010284 | 1 associated lipids |
| Ectodermal Dysplasia | D004476 | 1 associated lipids |
| Tooth Erosion | D014077 | 2 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| From the Centers for Disease Control and Prevention. Fluoroquinolone resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999. | 2000 | JAMA | pmid:11183745 | |
| West S | The red eye. | 2000 | N. Engl. J. Med. | pmid:11184764 |
| McNabb J et al. | Comparison of azithromycin leukocyte disposition in healthy volunteers and volunteers with AIDS. | 2000 | Int. J. Antimicrob. Agents | pmid:11185411 |
| Amsden GW et al. | A study of the pharmacokinetics of azithromycin and nelfinavir when coadministered in healthy volunteers. | 2000 | J Clin Pharmacol | pmid:11185676 |
| Garasiuta EG | [Surgical treatment of ulnar and pre-patellar bursitis under ambulatory conditions]. | 2000 | Voen Med Zh | pmid:12886538 |
| Infection fighters. MAC prevention takes a holiday. | 2000 | TreatmentUpdate | pmid:12132450 | |
| Zuckerman JM | The newer macrolides: azithromycin and clarithromycin. | 2000 | Infect. Dis. Clin. North Am. | pmid:10829265 |
| Schissel DJ et al. | Azithromycin eruption in infectious mononucleosis: a proposed mechanism of interaction. | 2000 | Cutis | pmid:10738636 |
| Valleala H et al. | [The unknown SAPHO]. | 2000 | Duodecim | pmid:12017613 |
| Giacometti A et al. | Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. | 2000 | J. Antimicrob. Chemother. | pmid:10747821 |
| Bujanda L et al. | Ranitidine bismuth citrate plus azithromycin for Helicobacter pylori eradication. | 2000 | J. Clin. Gastroenterol. | pmid:10777206 |
| Ress BD and Gross EM | Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report. | 2000 | Ann. Otol. Rhinol. Laryngol. | pmid:10778901 |
| Miller SA et al. | Chlamydia pneumoniae activates nuclear factor kappaB and activator protein 1 in human vascular smooth muscle and induces cellular proliferation. | 2000 | J. Surg. Res. | pmid:10781378 |
| Skerk V et al. | Comparative analysis of azithromycin and doxycycline efficacy in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum. | 2000 | J Chemother | pmid:10789560 |
| Sasaki TY and Sumida KN | Angioimmunoblastic T-cell lymphoma (AIL-TCL) following macrolide administration. | 2000 | Hawaii Med J | pmid:10800250 |
| Somani J et al. | Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. | 2000 | J. Infect. Dis. | pmid:10762573 |
| El-Sadr WM et al. | Discontinuation of prophylaxis for Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS. | 2000 | N. Engl. J. Med. | pmid:10766581 |
| Brieland JK et al. | Efficacy of SCH27899 in an animal model of Legionnaires' disease using immunocompromised A/J mice. | 2000 | Antimicrob. Agents Chemother. | pmid:10770771 |
| Laming AC et al. | A targeted, single-dose azithromycin strategy for trachoma. | 2000 | Med. J. Aust. | pmid:10772587 |
| Turcinov D et al. | Failure of azithromycin in treatment of Brill-Zinsser disease. | 2000 | Antimicrob. Agents Chemother. | pmid:10817744 |
| Tsitsika A et al. | Single-oral-dose azithromycin prophylaxis against experimental streptococcal or staphylococcal aortic valve endocarditis. | 2000 | Antimicrob. Agents Chemother. | pmid:10817749 |
| Bin XX et al. | Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice. | 2000 | Antimicrob. Agents Chemother. | pmid:10817751 |
| Semaan HB et al. | The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease. | 2000 | J. Cardiovasc. Pharmacol. | pmid:11026657 |
| Miller JM and Martin DH | Treatment of Chlamydia trachomatis infections in pregnant women. | 2000 | Drugs | pmid:11030469 |
| Waterer GW et al. | Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy. | 2000 | Chest | pmid:11115489 |
| Esposito S and Ascione T | Short-course treatment for acute tonsillopharyngitis. | 2000 | Int. J. Antimicrob. Agents | pmid:11118866 |
| Gandhi R et al. | Validated LC method for in-vitro analysis of azithromycin using electrochemical detection. | 2000 | J Pharm Biomed Anal | pmid:11095310 |
| Bowman RJ et al. | Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. | 2000 | Invest. Ophthalmol. Vis. Sci. | pmid:11095598 |
| Calabrese C et al. | Pantoprazole, azithromycin and tinidazole: short duration triple therapy for eradication of Helicobacter pylori infection. | 2000 | Aliment. Pharmacol. Ther. | pmid:11121909 |
| DeAbate CA et al. | The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis. | 2000 | Respir Med | pmid:11127487 |
| Skerk V et al. | Duration of clinical symptoms in female patients with acute urethral syndrome caused by Ureaplasma urealyticum treated with azithromycin or doxycycline. | 2000 | J Chemother | pmid:11154040 |
| Macaigne G et al. | [Acute pseudoangiocholitic hepatitis probably induced by azithromycin]. | 2000 | Gastroenterol. Clin. Biol. | pmid:11084438 |
| Alvarez MP et al. | [Pharmacovigilance study of azithromycin tablets (500 mg) in the treatment of adult patients with respiratory tract infections]. | 2000 | Rev Esp Quimioter | pmid:11086281 |
| Nagai K et al. | In vitro development of resistance to ceftriaxone, cefprozil and azithromycin in Streptococcus pneumoniae. | 2000 | J. Antimicrob. Chemother. | pmid:11102409 |
| Ianaro A et al. | Anti-inflammatory activity of macrolide antibiotics. | 2000 | J. Pharmacol. Exp. Ther. | pmid:10604943 |
| Sader H and Del'Alamo L | Etest compared to broth microdilution: discrepant results when testing macrolides against Streptococcus pneumoniae indicate a need for better clinical and serum level/MIC correlation. | 2000 | Braz J Infect Dis | pmid:11063559 |
| Putnam SD et al. | Pharyngeal colonization prevalence rates for Streptococcus pyogenes and Streptococcus pneumoniae in a respiratory chemoprophylaxis intervention study using azithromycin. | 2000 | Clin. Microbiol. Infect. | pmid:11168029 |
| Fogarty C et al. | Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin. | 2000 | Clin. Infect. Dis. | pmid:10987733 |
| Schilling F and Wagner AD | [Azithromycin: an anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report]. | 2000 | Z Rheumatol | pmid:11142932 |
| Powers JL et al. | Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients. | 2000 | Pediatr. Infect. Dis. J. | pmid:11144401 |
| Duran JM and Amsden GW | Azithromycin: indications for the future? | 2000 | Expert Opin Pharmacother | pmid:11249533 |
| Schneider CA et al. | In vivo uptake of azithromycin in human coronary plaques. | 2000 | Am. J. Cardiol. | pmid:11018204 |
| Kuper JI and D'Aprile M | Drug-Drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease. | 2000 | Clin Pharmacokinet | pmid:11020135 |
| McBroom JW | Medical management of interstitial pregnancy with a retained IUD. A case report. | 2000 | J Reprod Med | pmid:10900583 |
| Koch CC et al. | Apoptosis, oxidative metabolism and interleukin-8 production in human neutrophils exposed to azithromycin: effects of Streptococcus pneumoniae. | 2000 | J. Antimicrob. Chemother. | pmid:10882684 |
| Herrera D et al. | The periodontal abscess (II). Short-term clinical and microbiological efficacy of 2 systemic antibiotic regimes. | 2000 | J. Clin. Periodontol. | pmid:10883868 |
| Anderson JL and Muhlestein JB | The ACADEMIC study in perspective (Azithromycin in coronary artery disease: elimination of myocardial infection with Chlamydia). | 2000 | J. Infect. Dis. | pmid:10839761 |
| Dunne MW | Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial. | 2000 | J. Infect. Dis. | pmid:10839762 |
| Jackson LA | Description and status of the azithromycin and coronary events study (ACES). | 2000 | J. Infect. Dis. | pmid:10839763 |
| Raja Babu KK et al. | Confluent and reticulate papillomatosis: successful treatment with azithromycin. | 2000 | Br. J. Dermatol. | pmid:10848767 |
| SendaÄŸ F et al. | Single dose oral azithromycin versus seven day doxycycline in the treatment of non-gonococcal mucopurulent endocervicitis. | 2000 | Aust N Z J Obstet Gynaecol | pmid:10870778 |
| Gruber F et al. | Treatment of early syphilis with azithromycin. | 2000 | J Chemother | pmid:10877520 |
| Tateda K et al. | Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response. | 2000 | J. Infect. Chemother. | pmid:11810524 |
| Ernst EJ et al. | Comparison of the serum and intracellular pharmacokinetics of azithromycin in healthy and diabetic volunteers. | 2000 | Pharmacotherapy | pmid:10853621 |
| Criqui GI et al. | Effects of azithromycin on ozone-induced airway neutrophilia and cytokine release. | 2000 | Eur. Respir. J. | pmid:10853849 |
| Heikkinen T et al. | The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. | 2000 | BJOG | pmid:10847234 |
| Chinh NT et al. | A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. | 2000 | Antimicrob. Agents Chemother. | pmid:10858343 |
| González de Aledo Linos A and GarcÃa Merino J | [Control of a school outbreak of serogroup B meningococcal disease by chemoprophylaxis with azithromycin and ciprofloxacin]. | 2000 | An. Esp. Pediatr. | pmid:11521657 |
| Vcev A et al. | Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer. | 2000 | Aliment. Pharmacol. Ther. | pmid:10632647 |
| Steen R et al. | Evidence of declining STD prevalence in a South African mining community following a core-group intervention. | 2000 | Sex Transm Dis | pmid:10654860 |
| Oksi J | [Diagnostics and treatment of Lyme borreliosis]. | 2000 | Duodecim | pmid:11787113 |
| Miyazaki S and Yamaguchi K | [In vitro and in vivo antibacterial activities of azithromycin]. | 2000 | Jpn J Antibiot | pmid:12572087 |
| Shiba K | [Pharmacokinetics and tissue distribution of azithromycin in humans]. | 2000 | Jpn J Antibiot | pmid:12572088 |
| Enogaki K | [Transport to an infected site of azithromycin by phagocyte cells]. | 2000 | Jpn J Antibiot | pmid:12572089 |
| Oizumi K | [Clinical evaluation of azithromycin for respiratory infectious diseases]. | 2000 | Jpn J Antibiot | pmid:12572090 |
| Nakayama I | [Clinical studies of azithromycin, a new macrolide antibiotic, for infections in the field of surgery]. | 2000 | Jpn J Antibiot | pmid:12572091 |
| Sunakawa K | [Summary of the clinical studies with azithromycin in the pediatric fields]. | 2000 | Jpn J Antibiot | pmid:12572092 |
| Naoya M | [The clinical study of azithromycin in otolaryngologic infection]. | 2000 | Jpn J Antibiot | pmid:12572093 |
| Arata J | [Azithromycin in the field of dermatology]. | 2000 | Jpn J Antibiot | pmid:12572094 |
| Sasaki J | [Azithromycin in dentistry and oral surgery]. | 2000 | Jpn J Antibiot | pmid:12572095 |
| Higa F and Saito A | [Clinical safety of azithromycin]. | 2000 | Jpn J Antibiot | pmid:12572096 |
| Grayston JT | Secondary prevention antibiotic treatment trials for coronary artery disease. | 2000 | Circulation | pmid:11023925 |
| Muhlestein JB et al. | Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. | 2000 | Circulation | pmid:11023928 |
| Bharat V and Mohanty B | Bleeding complication during coumarin therapy due to amiodarone and azithromycin. | 2000 | J Assoc Physicians India | pmid:11273517 |
| Gulati R et al. | Comparative bioavailability of two formulations of azithromycin. | 2000 | J Assoc Physicians India | pmid:11273540 |
| Powell FC | What's going on in rosacea? | 2000 | J Eur Acad Dermatol Venereol | pmid:11305376 |
| Guzey M et al. | Three-day course of oral azithromycin vs topical oxytetracycline/polymyxin in treatment of active endemic trachoma. | 2000 Jul-Aug | Jpn. J. Ophthalmol. | pmid:10974295 |
| Schouenborg P et al. | Azithromycin versus pivampicillin in the treatment of acute exacerbations of chronic bronchitis: a single-blind, double-dummy, multicentre study. | 2000 May-Jun | J. Int. Med. Res. | pmid:10983860 |
| Barsic B et al. | Comparison of azithromycin and doxycycline in the treatment of erythema migrans. | 2000 May-Jun | Infection | pmid:10879639 |
| Bayoumi AM and Redelmeier DA | Decision analysis with cumulative prospect theory. | 2000 Oct-Dec | Med Decis Making | pmid:11059473 |
| Scaglione F et al. | In vitro comparative dynamics of modified-release clarithromycin and of azithromycin. | 2000 Sep-Oct | Chemotherapy | pmid:10965100 |
| Thompson C et al. | A family cluster of Chlamydia trachomatis infection. | 2001 | BMJ | pmid:11408308 |
| Jacobson GF et al. | A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. | 2001 | Am. J. Obstet. Gynecol. | pmid:11408852 |
| Matsunaga T | [Pharmacological and pharmacokinetic properties of azithromycin (Zithromac), a novel 15-membered ring macrolide antibacterial agent]. | 2001 | Nippon Yakurigaku Zasshi | pmid:11411344 |
| Gerber MA and Tanz RR | New approaches to the treatment of group A streptococcal pharyngitis. | 2001 | Curr. Opin. Pediatr. | pmid:11176244 |
| Conrad DA | Treatment of cat-scratch disease. | 2001 | Curr. Opin. Pediatr. | pmid:11176245 |
| Mamikoglu B and Mamikoglu O | Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report. | 2001 | Ann. Otol. Rhinol. Laryngol. | pmid:11201801 |
| Woolard S and Kenkel D | Heading off antibiotic resistance. | 2001 | Adv Nurse Pract | pmid:12420432 |
| Chahine C et al. | Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori. | 2001 | Am J Health Syst Pharm | pmid:11596697 |
| Weigl LB et al. | [Confluent and reticulate papillomatosis. Successful therapy with azithromycin]. | 2001 | Hautarzt | pmid:11715390 |
| Gray RH et al. | Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. | 2001 | Am. J. Obstet. Gynecol. | pmid:11717659 |
| Noedl H et al. | Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand. | 2001 | Acta Trop. | pmid:11495642 |
| Fraser-Hurt N et al. | Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma. | 2001 | Bull. World Health Organ. | pmid:11477966 |
| Bain DL et al. | Chlamydial genovar distribution after community wide antibiotic treatment. | 2001 | J. Infect. Dis. | pmid:11740734 |
| Nagata T et al. | [Two cases successfully treated with long-term administration of low-dosage azithromycin]. | 2001 | Jpn J Antibiot | pmid:12575407 |
| Sorvillo F et al. | Incidence and determinants of Pseudomonas aeruginosa infection among persons with HIV: association with hospital exposure. | 2001 | Am J Infect Control | pmid:11287873 |
| Edelstein PH et al. | In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. | 2001 | Antimicrob. Agents Chemother. | pmid:11451675 |
| Rubinstein E | Comparative safety of the different macrolides. | 2001 | Int. J. Antimicrob. Agents | pmid:11574199 |
| Skerk V et al. | Duration of clinical symptoms in female patients with acute urethral syndrome caused by Chlamydia trachomatis treated with azithromycin or doxycycline. | 2001 | J Chemother | pmid:11330365 |
| RodrÃguez Núñez A et al. | [Chemoprophylaxis of meningococcal disease with azithromycin and ciprofloxacin]. | 2001 | An. Esp. Pediatr. | pmid:11333489 |